S. Ohie

TAC‐101 (4‐[3,5‐bis(trimethylsilyl)benzamido]benzoic acid) Inhibits Spontaneous Mediastinal Lymph Node Metastasis Produced by Orthotopic Implantation of Lewis Lung Carcinoma

I. Saiki, Yuji Yamada, K. Murakami, 1999, Japanese journal of cancer research : Gann.

4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) induces apoptosis in colon cancer partially through the induction of Fas expression.

K. Kohno, N. Minagawa, K. Hirata, 2005, In vivo.

Histoculture drug response assay to monitor chemoresponse.

D. Aoki, Y. Udagawa, S. Nozawa, 2005, Methods in molecular medicine.

Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical response

D. Aoki, N. Susumu, Y. Udagawa, 2004, International Journal of Gynecologic Cancer.

Antitumor enediyne chromoprotein C-1027: mechanistic investigation of the chromophore-mediated self-decomposition pathway.

T. Otani, F. Hosoi, M. Inoue, 2006, Journal of the American Chemical Society.

Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.

R. Hoffman, A. Moossa, D. Aoki, 2000, Anticancer research.

A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: potential new therapy for ovarian clear cell adenocarcinoma.

D. Aoki, N. Susumu, F. Hosoi, 2008, Gynecologic oncology.